ACHV
Achieve Life Sciences, Inc. - Common Shares (ACHV)
$97
About Achieve Life Sciences, Inc. - Common Shares (ACHV)
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.
Details
Daily high
$3.09
Daily low
$2.92
Price at open
$3.09
52 Week High
$5.59
52 Week Low
$1.84
Market cap
108.9M
Dividend yield
0.00%
Volume
138,847
Avg. volume
217,450
P/E ratio
-2.35
Achieve Life Sciences, Inc. - Common Shares News
Details
Daily high
$3.09
Daily low
$2.92
Price at open
$3.09
52 Week High
$5.59
52 Week Low
$1.84
Market cap
108.9M
Dividend yield
0.00%
Volume
138,847
Avg. volume
217,450
P/E ratio
-2.35